Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

AZILSARTAN MEDOXOMIL

AZILSARTAN KAMEDOXOMIL

Standard Dose
EQ 40MG MEDOXOMIL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview AZILSARTAN MEDOXOMIL is listed in Drugs@FDA under application 214489 (ANDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient AZILSARTAN KAMEDOXOMIL Form and strength TABLET;ORAL - EQ 40MG MEDOXOMIL Sponsor LUPIN LTD Submission history Latest submission status date: 2024-07-18 00:00:00.

Structured Monograph

Clinical summary

Approval overview AZILSARTAN MEDOXOMIL is listed in Drugs@FDA under application 214489 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient AZILSARTAN KAMEDOXOMIL Form and strength TABLET;ORAL - EQ 40MG MEDOXOMIL Sponsor LUPIN LTD Submission history Latest submission status date: 2024-07-18 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
AZILSARTAN MEDOXOMIL (AZILSARTAN KAMEDOXOMIL) | Drug Monograph | MedicHelpline